Physician
Gunda, Sharad
Gunda, Sharad was paid $3.70M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoGUNDA, SHARAD
FRANKLIN, LA 70538
FRANKLIN, LA 70538
33aNPI1366517617assigned 11/22/2006
33bProvider typePediatrics Physician
28Total paid$3.70M
24GClaims108,317
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#39 of 230
Median peer was paid$429K
This provider vs. median8.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,030 | $650K | |
| 2019 | 16,153 | $670K | |
| 2020 | 15,369 | $418K | |
| 2021 | 16,337 | $521K | |
| 2022 | 16,042 | $515K | |
| 2023 | 15,747 | $501K | |
| 2024incomplete | 13,639 | $425K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 24,259 | 20,810 | $1.08M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 6,938 | 6,359 | $469K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 12% | 1,257 | 1,034 | $426K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.9% | 3,455 | 3,330 | $255K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.6% | 7,735 | 7,131 | $206K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 2,894 | 2,767 | $192K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.4% | 2,519 | 2,349 | $164K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.4% | 2,108 | 1,972 | $127K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.0% | 8,160 | 7,637 | $111K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.8% | 1,426 | 1,339 | $103K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.7% | 309 | 250 | $99K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 4,728 | 4,454 | $66K |
62 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 1,691 | $64K |
| 92551 | 1.6% | 7,790 | $61K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 634 | $47K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.0% | 665 | $39K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 3,434 | $37K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 764 | $34K |
| 90620 | <1% | 862 | $14K | |
| 99173 | <1% | 7,905 | $14K | |
| 90651 | <1% | 1,382 | $10K | |
| 99188 | <1% | 497 | $10K | |
| 90474 | <1% | 879 | $8K | |
| 83655 | <1% | 723 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 101 | $5K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 401 | $5K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 58 | $5K |
| 0001A | <1% | 123 | $5K | |
| 0002A | <1% | 126 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 328 | $4K |
| 87634 | <1% | 72 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 175 | $2K |
| 90670 | <1% | 1,976 | $2K | |
| 90734 | <1% | 590 | $2K | |
| 99499 | <1% | 162 | $2K | |
| 85018 | <1% | 805 | $1K | |
| 0071A | <1% | 53 | $1K | |
| 95115 | <1% | 169 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 16 | $1K |
| 90473 | <1% | 105 | $980.48 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 20 | $975.07 |
| 99381 | <1% | 12 | $839.19 | |
| 90688 | <1% | 603 | $744.21 | |
| 0072A | <1% | 16 | $677.04 | |
| 90619 | <1% | 575 | $605.36 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 16 | $526.35 |
| 90715 | <1% | 327 | $322.60 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 31 | $314.88 |
| 81025 | <1% | 43 | $227.16 | |
| 90716 | <1% | 248 | $194.84 | |
| 90686 | <1% | 297 | $157.86 | |
| 90697 | <1% | 348 | $150.00 | |
| 90621 | <1% | 17 | $149.14 | |
| 90660 | <1% | 35 | $147.72 | |
| 96160 | <1% | 138 | $113.26 | |
| 90680 | <1% | 892 | $97.06 | |
| 90672 | <1% | 154 | $90.00 | |
| 90658 | <1% | 91 | $87.44 | |
| 90710 | <1% | 675 | $81.25 | |
| 90707 | <1% | 253 | $70.92 | |
| 96161 | <1% | 24 | $65.12 | |
| 81002 | <1% | 16 | $32.07 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 18 | $13.92 |
| 90633 | <1% | 2,631 | $4.52 | |
| 90380 | <1% | 13 | $0.01 | |
| 90700 | 0% | 332 | $0.00 | |
| 90685 | 0% | 34 | $0.00 | |
| 90687 | 0% | 84 | $0.00 | |
| 91300 | 0% | 285 | $0.00 | |
| 90713 | 0% | 72 | $0.00 | |
| 90744 | 0% | 437 | $0.00 | |
| 90698 | 0% | 1,194 | $0.00 | |
| 91307 | 0% | 96 | $0.00 | |
| 97802 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.